EP2137192
Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.4.2008EP published:
19.2.2014EP application number:
08735211.8
EPO information:
European Patent Register
Max expiry date:
13.4.2028
Title:
Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
Timeline
Today
14.4.2008EP application
19.2.2014EP Publication
Owner
Name:
Neurodyn Life Sciences Inc.Address:
Suite 508 NRC-INH 550 University Ave.,, Charlottetown, P.E.I., C1A 4P3, CA
Inventor
Name:
MAELICKE, AlfredAddress:
Nieder-Olm, DE
Classification
Categories:
C07D 491/10, A61K 31/4355, A61P 25/00